In the present study,the partial gene sequences of P32 protein,an immunogenic envelope protein of Capripoxviruses (CaPV),were analyzed to assess the genetic relationship among sheeppox and goatpox virus isolates,and r...In the present study,the partial gene sequences of P32 protein,an immunogenic envelope protein of Capripoxviruses (CaPV),were analyzed to assess the genetic relationship among sheeppox and goatpox virus isolates,and restriction enzyme specific PCR-RFLP was developed to differentiate CaPV strains.A total of six goatpox virus (GTPV) and nine sheeppox virus (SPPV) isolates of Indian origin were included in the sequence analysis of the attachment gene.The sequence analysis revealed a high degree of sequence identity among all the Indian SPPV and GTPV isolates at both nucleotide and amino acid levels.Phylogenetic analysis showed three distinct clusters of SPPV,GTPV and Lumpy skin disease virus (LSDV) isolates.Further,multiple sequence alignment revealed a unique change at G120A in all GTPV isolates resulting in the formation of Dra I restriction site in lieu of EcoR I,which is present in SPPV isolates studied.This change was unique and exploited to develop restriction enzyme specific PCR-RFLP for detection and differentiation of SPPV and GTPV strains.The optimized PCR-RFLP was validated using a total of fourteen (n=14) cell culture isolates and twenty two (n=22) known clinical samples of CaPV.The Restriction Enzyme specific PCR-RFLP to differentiate both species will allow a rapid differential diagnosis during CaPV outbreaks particularly in mixed flocks of sheep and goats and could be an adjunct/supportive tool for complete gene or virus genome sequencing methods.展开更多
以减毒鼠伤寒沙门菌X 4550为载体,构建编码缺失跨膜区和疏水区的山羊痘病毒P32基因的新型口服活载体D N A疫苗,通过体外传代培养、大剂量接种试验、免疫组织化学试验、ELISA等对其安全性、稳定性、免疫原性及免疫效果等进行综合检测评...以减毒鼠伤寒沙门菌X 4550为载体,构建编码缺失跨膜区和疏水区的山羊痘病毒P32基因的新型口服活载体D N A疫苗,通过体外传代培养、大剂量接种试验、免疫组织化学试验、ELISA等对其安全性、稳定性、免疫原性及免疫效果等进行综合检测评价。结果表明,X4550/pVAX1-P32在体外可稳定传代100代以上,小鼠口服1×10^(10)CF U X4550/pVAX1-P32后存活率为100%,接种后第10天仍能从脾中分离到X4550/pVAX1-P32,表明X4550/pVAX1-P32在体内外均具有良好的安全性和稳定性。免疫组织化学试验结果显示免疫小鼠脾细胞内有黄褐色粗颗粒,表明X4550能将pVAX1-P32有效递呈至免疫效应细胞并在其内表达具有生物活性的P32蛋白。ELISA结果显示,X4550/pVAX1-P32免疫组的抗体水平显著高于pVAX1-P32免疫组(0.01<P<0.05),且X4550/pVAX1-P32免疫组能诱导持续时间更长的抗体水平(P<0.01),表明活载体疫苗X4550/pVAX1-P32具有良好的免疫原性,能够诱导机体产生持久的、高水平的免疫应答,这为羊痘新型疫苗的研究和应用奠定了基础。展开更多
文摘In the present study,the partial gene sequences of P32 protein,an immunogenic envelope protein of Capripoxviruses (CaPV),were analyzed to assess the genetic relationship among sheeppox and goatpox virus isolates,and restriction enzyme specific PCR-RFLP was developed to differentiate CaPV strains.A total of six goatpox virus (GTPV) and nine sheeppox virus (SPPV) isolates of Indian origin were included in the sequence analysis of the attachment gene.The sequence analysis revealed a high degree of sequence identity among all the Indian SPPV and GTPV isolates at both nucleotide and amino acid levels.Phylogenetic analysis showed three distinct clusters of SPPV,GTPV and Lumpy skin disease virus (LSDV) isolates.Further,multiple sequence alignment revealed a unique change at G120A in all GTPV isolates resulting in the formation of Dra I restriction site in lieu of EcoR I,which is present in SPPV isolates studied.This change was unique and exploited to develop restriction enzyme specific PCR-RFLP for detection and differentiation of SPPV and GTPV strains.The optimized PCR-RFLP was validated using a total of fourteen (n=14) cell culture isolates and twenty two (n=22) known clinical samples of CaPV.The Restriction Enzyme specific PCR-RFLP to differentiate both species will allow a rapid differential diagnosis during CaPV outbreaks particularly in mixed flocks of sheep and goats and could be an adjunct/supportive tool for complete gene or virus genome sequencing methods.
文摘以减毒鼠伤寒沙门菌X 4550为载体,构建编码缺失跨膜区和疏水区的山羊痘病毒P32基因的新型口服活载体D N A疫苗,通过体外传代培养、大剂量接种试验、免疫组织化学试验、ELISA等对其安全性、稳定性、免疫原性及免疫效果等进行综合检测评价。结果表明,X4550/pVAX1-P32在体外可稳定传代100代以上,小鼠口服1×10^(10)CF U X4550/pVAX1-P32后存活率为100%,接种后第10天仍能从脾中分离到X4550/pVAX1-P32,表明X4550/pVAX1-P32在体内外均具有良好的安全性和稳定性。免疫组织化学试验结果显示免疫小鼠脾细胞内有黄褐色粗颗粒,表明X4550能将pVAX1-P32有效递呈至免疫效应细胞并在其内表达具有生物活性的P32蛋白。ELISA结果显示,X4550/pVAX1-P32免疫组的抗体水平显著高于pVAX1-P32免疫组(0.01<P<0.05),且X4550/pVAX1-P32免疫组能诱导持续时间更长的抗体水平(P<0.01),表明活载体疫苗X4550/pVAX1-P32具有良好的免疫原性,能够诱导机体产生持久的、高水平的免疫应答,这为羊痘新型疫苗的研究和应用奠定了基础。
